Works matching DE "OLAPARIB"

Results: 218
    1

    Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.

    Published in:
    Journal of Gynecologic Oncology, 2025, v. 36, n. 4, p. 1, doi. 10.3802/jgo.2025.36.e118
    By:
    • Shin Nishio;
    • Tadaaki Nishikawa;
    • Masahiko Mori;
    • Shoji Kamiura;
    • Toshiyuki Sumi;
    • Mayu Yunokawa;
    • Yuichi Imai;
    • Eiji Kondo;
    • Kazuhiro Takehara;
    • Hirokuni Takano;
    • Wataru Kudaka;
    • Nobuhiro Kado;
    • Wataru Yamagami;
    • Hidenori Kato;
    • Koji Nishino;
    • Tomoka Usami;
    • Junzo Hamanishi;
    • Masahiro Nii;
    • Itsumi Takaya;
    • Aikou Okamoto
    Publication type:
    Article
    2
    3
    4
    5
    6

    Role of PARP inhibitors in prostate cancer.

    Published in:
    Central European Journal of Urology (2080-4806), 2024, v. 77, n. 3, p. 424, doi. 10.5173/ceju.2024.72.R1
    By:
    • Szczotka, Julia;
    • Szpila, Gabriela;
    • Hejduk, Michał;
    • Mucha, Ewa;
    • Rudel, Jolanta;
    • Kępiński, Michał;
    • Kaletka, Julia;
    • Ryszawy, Jakub;
    • Zapala, Piotr;
    • Tsuboi, Ichiro;
    • Matsukawa, Akihiro;
    • Miszczyk, Marcin;
    • Fazekas, Tamas;
    • Zattoni, Fabio;
    • Bryniarski, Piotr;
    • Rajwa, Paweł
    Publication type:
    Article
    7

    Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00632-8
    By:
    • Morganti, Stefania;
    • Jin, Qingchun;
    • Vincuilla, Julie;
    • Buehler, Ryan;
    • Ryan, Sean;
    • Stokes, Samantha;
    • Parker, Tonia;
    • Mittendorf, Elizabeth A.;
    • King, Tari A.;
    • Weiss, Anna;
    • Partridge, Ann H.;
    • Bychkovsky, Brittany L.;
    • Curigliano, Giuseppe;
    • Tayob, Nabihah;
    • Lin, Nancy U.;
    • Garber, Judy E.;
    • Tolaney, Sara M.;
    • Lynce, Filipa
    Publication type:
    Article
    8
    9
    10
    11

    Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.898150
    By:
    • Ryota Tashiro;
    • Hitoshi Kawazoe;
    • Kanako Mamishin;
    • Keisuke Seto;
    • Ryoko Udagawa;
    • Yoshimasa Saito;
    • Hironobu Hashimoto;
    • Tatsunori Shimoi;
    • Kan Yonemori;
    • Masahito Yonemura;
    • Hiroyuki Terakado;
    • Toshikatsu Kawasaki;
    • Tetsuya Furukawa;
    • Tomonori Nakamura
    Publication type:
    Article
    12

    DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8- gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.844250
    By:
    • Merlini, Alessandra;
    • Centomo, Maria Laura;
    • Ferrero, Giulio;
    • Chiabotto, Giulia;
    • Miglio, Umberto;
    • Berrino, Enrico;
    • Giordano, Giorgia;
    • Brusco, Silvia;
    • Pisacane, Alberto;
    • Maldi, Elena;
    • Sarotto, Ivana;
    • Capozzi, Federica;
    • Lano, Cristina;
    • Isella, Claudio;
    • Crisafulli, Giovanni;
    • Aglietta, Massimo;
    • Dei Tos, Angelo Paolo;
    • Sbaraglia, Marta;
    • Sangiolo, Dario;
    • D’Ambrosio, Lorenzo
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 5, p. 1, doi. 10.3802/jgo.2021.32.e82
    By:
    • Keiichi Fujiwara;
    • Hiroyuki Fujiwara;
    • Hiroyuki Yoshida;
    • Toyomi Satoh;
    • Kan Yonemori;
    • Shoji Nagao;
    • Takashi Matsumoto;
    • Hiroaki Kobayashi;
    • Bourgeois, Hughes;
    • Harter, Philipp;
    • Mosconi, Anna Maria;
    • Vazquez, Isabel Palacio;
    • Reinthaller, Alexander;
    • Tomoko Fujita;
    • Rowe, Philip;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    New treatment strategy for ovarian cancer with a BRCA gene mutation.

    Published in:
    European Journal of Gynaecological Oncology, 2021, v. 42, n. 1, p. 1, doi. 10.31083/j.ejgo.2021.01.2251
    By:
    • Tadahiro Shoji;
    • Kotoka Kikuchi;
    • Hayato Kogita;
    • Nanako Jonai;
    • Hidetoshi Tomabechi;
    • Akiko Kudoh;
    • Eriko Takatori;
    • Takayuki Nagasawa;
    • Masahiro Kagabu;
    • Tsukasa Baba
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature.

    Published in:
    BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02569-3
    By:
    • Ishimoto, Hiroshi;
    • Sakamoto, Noriho;
    • Kido, Takashi;
    • Ozasa, Mutsumi;
    • Tsutsui, Shin;
    • Mori, Mayako;
    • Setoguchi, Daichi;
    • Takemoto, Shinnosuke;
    • Obase, Yasushi;
    • Ishimatsu, Yuji;
    • Tomonaga, Chiharu;
    • Matsumoto, Kanako;
    • Morisaki, Sachiko;
    • Miura, Kiyonori;
    • Mukae, Hiroshi
    Publication type:
    Article
    49

    Olaparib.

    Published in:
    Australian Prescriber, 2017, v. 40, n. 1, p. 37, doi. 10.18773/austprescr.2016.093
    Publication type:
    Article
    50